img

Global Split Influenza Vaccine Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Split Influenza Vaccine Market Insights, Forecast to 2034

Influenza virus split vaccine is made by inoculating chicken embryos with influenza virus strains recommended by the World Health Organization (WHO) and approved by the national drug administration department, cultured, harvested virus liquid, virus inactivated, purified, and cracked. For the prevention of influenza caused by this type of virus.
Global Split Influenza Vaccine market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Split Influenza Vaccine industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Split Influenza Vaccine market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Split Influenza Vaccine market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Sanofi Pasteur
CSL Seqirus
GSK
Seqirus, Inc.
straZeneca
Dalian Yali Peak
Segment by Type
Aldult
Child

Segment by Application


Hospital
Clinic

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Split Influenza Vaccine plant distribution, commercial date of Split Influenza Vaccine, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Split Influenza Vaccine introduction, etc. Split Influenza Vaccine Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Split Influenza Vaccine
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Split Influenza Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Split Influenza Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Aldult
1.2.3 Child
1.3 Market by Application
1.3.1 Global Split Influenza Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Split Influenza Vaccine Sales Estimates and Forecasts 2018-2029
2.2 Global Split Influenza Vaccine Revenue by Region
2.2.1 Global Split Influenza Vaccine Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Split Influenza Vaccine Revenue by Region (2018-2024)
2.2.3 Global Split Influenza Vaccine Revenue by Region (2024-2029)
2.2.4 Global Split Influenza Vaccine Revenue Market Share by Region (2018-2029)
2.3 Global Split Influenza Vaccine Sales Estimates and Forecasts 2018-2029
2.4 Global Split Influenza Vaccine Sales by Region
2.4.1 Global Split Influenza Vaccine Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Split Influenza Vaccine Sales by Region (2018-2024)
2.4.3 Global Split Influenza Vaccine Sales by Region (2024-2029)
2.4.4 Global Split Influenza Vaccine Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Split Influenza Vaccine Sales by Manufacturers
3.1.1 Global Split Influenza Vaccine Sales by Manufacturers (2018-2024)
3.1.2 Global Split Influenza Vaccine Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Split Influenza Vaccine in 2022
3.2 Global Split Influenza Vaccine Revenue by Manufacturers
3.2.1 Global Split Influenza Vaccine Revenue by Manufacturers (2018-2024)
3.2.2 Global Split Influenza Vaccine Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Split Influenza Vaccine Revenue in 2022
3.3 Global Key Players of Split Influenza Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Split Influenza Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Split Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Split Influenza Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Split Influenza Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Split Influenza Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Split Influenza Vaccine Sales by Type
4.1.1 Global Split Influenza Vaccine Historical Sales by Type (2018-2024)
4.1.2 Global Split Influenza Vaccine Forecasted Sales by Type (2024-2029)
4.1.3 Global Split Influenza Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Split Influenza Vaccine Revenue by Type
4.2.1 Global Split Influenza Vaccine Historical Revenue by Type (2018-2024)
4.2.2 Global Split Influenza Vaccine Forecasted Revenue by Type (2024-2029)
4.2.3 Global Split Influenza Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Split Influenza Vaccine Price by Type
4.3.1 Global Split Influenza Vaccine Price by Type (2018-2024)
4.3.2 Global Split Influenza Vaccine Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Split Influenza Vaccine Sales by Application
5.1.1 Global Split Influenza Vaccine Historical Sales by Application (2018-2024)
5.1.2 Global Split Influenza Vaccine Forecasted Sales by Application (2024-2029)
5.1.3 Global Split Influenza Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Split Influenza Vaccine Revenue by Application
5.2.1 Global Split Influenza Vaccine Historical Revenue by Application (2018-2024)
5.2.2 Global Split Influenza Vaccine Forecasted Revenue by Application (2024-2029)
5.2.3 Global Split Influenza Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Split Influenza Vaccine Price by Application
5.3.1 Global Split Influenza Vaccine Price by Application (2018-2024)
5.3.2 Global Split Influenza Vaccine Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Split Influenza Vaccine Market Size by Type
6.1.1 US & Canada Split Influenza Vaccine Sales by Type (2018-2029)
6.1.2 US & Canada Split Influenza Vaccine Revenue by Type (2018-2029)
6.2 US & Canada Split Influenza Vaccine Market Size by Application
6.2.1 US & Canada Split Influenza Vaccine Sales by Application (2018-2029)
6.2.2 US & Canada Split Influenza Vaccine Revenue by Application (2018-2029)
6.3 US & Canada Split Influenza Vaccine Market Size by Country
6.3.1 US & Canada Split Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Split Influenza Vaccine Sales by Country (2018-2029)
6.3.3 US & Canada Split Influenza Vaccine Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Split Influenza Vaccine Market Size by Type
7.1.1 Europe Split Influenza Vaccine Sales by Type (2018-2029)
7.1.2 Europe Split Influenza Vaccine Revenue by Type (2018-2029)
7.2 Europe Split Influenza Vaccine Market Size by Application
7.2.1 Europe Split Influenza Vaccine Sales by Application (2018-2029)
7.2.2 Europe Split Influenza Vaccine Revenue by Application (2018-2029)
7.3 Europe Split Influenza Vaccine Market Size by Country
7.3.1 Europe Split Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Split Influenza Vaccine Sales by Country (2018-2029)
7.3.3 Europe Split Influenza Vaccine Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Split Influenza Vaccine Market Size
8.1.1 China Split Influenza Vaccine Sales (2018-2029)
8.1.2 China Split Influenza Vaccine Revenue (2018-2029)
8.2 China Split Influenza Vaccine Market Size by Application
8.2.1 China Split Influenza Vaccine Sales by Application (2018-2029)
8.2.2 China Split Influenza Vaccine Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Split Influenza Vaccine Market Size by Type
9.1.1 Asia Split Influenza Vaccine Sales by Type (2018-2029)
9.1.2 Asia Split Influenza Vaccine Revenue by Type (2018-2029)
9.2 Asia Split Influenza Vaccine Market Size by Application
9.2.1 Asia Split Influenza Vaccine Sales by Application (2018-2029)
9.2.2 Asia Split Influenza Vaccine Revenue by Application (2018-2029)
9.3 Asia Split Influenza Vaccine Sales by Region
9.3.1 Asia Split Influenza Vaccine Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Split Influenza Vaccine Revenue by Region (2018-2029)
9.3.3 Asia Split Influenza Vaccine Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Split Influenza Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America Split Influenza Vaccine Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Split Influenza Vaccine Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Split Influenza Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America Split Influenza Vaccine Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Split Influenza Vaccine Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Split Influenza Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Split Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Split Influenza Vaccine Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Split Influenza Vaccine Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Sanofi Pasteur
11.1.1 Sanofi Pasteur Company Information
11.1.2 Sanofi Pasteur Overview
11.1.3 Sanofi Pasteur Split Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Sanofi Pasteur Split Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Pasteur Recent Developments
11.2 CSL Seqirus
11.2.1 CSL Seqirus Company Information
11.2.2 CSL Seqirus Overview
11.2.3 CSL Seqirus Split Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 CSL Seqirus Split Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CSL Seqirus Recent Developments
11.3 GSK
11.3.1 GSK Company Information
11.3.2 GSK Overview
11.3.3 GSK Split Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 GSK Split Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GSK Recent Developments
11.4 Seqirus, Inc.
11.4.1 Seqirus, Inc. Company Information
11.4.2 Seqirus, Inc. Overview
11.4.3 Seqirus, Inc. Split Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Seqirus, Inc. Split Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Seqirus, Inc. Recent Developments
11.5 straZeneca
11.5.1 straZeneca Company Information
11.5.2 straZeneca Overview
11.5.3 straZeneca Split Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 straZeneca Split Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 straZeneca Recent Developments
11.6 Dalian Yali Peak
11.6.1 Dalian Yali Peak Company Information
11.6.2 Dalian Yali Peak Overview
11.6.3 Dalian Yali Peak Split Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Dalian Yali Peak Split Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Dalian Yali Peak Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Split Influenza Vaccine Industry Chain Analysis
12.2 Split Influenza Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Split Influenza Vaccine Production Mode & Process
12.4 Split Influenza Vaccine Sales and Marketing
12.4.1 Split Influenza Vaccine Sales Channels
12.4.2 Split Influenza Vaccine Distributors
12.5 Split Influenza Vaccine Customers
13 Market Dynamics
13.1 Split Influenza Vaccine Industry Trends
13.2 Split Influenza Vaccine Market Drivers
13.3 Split Influenza Vaccine Market Challenges
13.4 Split Influenza Vaccine Market Restraints
14 Key Findings in The Global Split Influenza Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Split Influenza Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Aldult
Table 3. Major Manufacturers of Child
Table 4. Global Split Influenza Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Split Influenza Vaccine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Split Influenza Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Split Influenza Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Split Influenza Vaccine Revenue Market Share by Region (2018-2024)
Table 9. Global Split Influenza Vaccine Revenue Market Share by Region (2024-2029)
Table 10. Global Split Influenza Vaccine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Split Influenza Vaccine Sales by Region (2018-2024) & (K Units)
Table 12. Global Split Influenza Vaccine Sales by Region (2024-2029) & (K Units)
Table 13. Global Split Influenza Vaccine Sales Market Share by Region (2018-2024)
Table 14. Global Split Influenza Vaccine Sales Market Share by Region (2024-2029)
Table 15. Global Split Influenza Vaccine Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Split Influenza Vaccine Sales Share by Manufacturers (2018-2024)
Table 17. Global Split Influenza Vaccine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Split Influenza Vaccine Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Split Influenza Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Split Influenza Vaccine Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Split Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Split Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Split Influenza Vaccine as of 2022)
Table 23. Global Key Manufacturers of Split Influenza Vaccine, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Split Influenza Vaccine, Product Offered and Application
Table 25. Global Key Manufacturers of Split Influenza Vaccine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Split Influenza Vaccine Sales by Type (2018-2024) & (K Units)
Table 28. Global Split Influenza Vaccine Sales by Type (2024-2029) & (K Units)
Table 29. Global Split Influenza Vaccine Sales Share by Type (2018-2024)
Table 30. Global Split Influenza Vaccine Sales Share by Type (2024-2029)
Table 31. Global Split Influenza Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Split Influenza Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Split Influenza Vaccine Revenue Share by Type (2018-2024)
Table 34. Global Split Influenza Vaccine Revenue Share by Type (2024-2029)
Table 35. Split Influenza Vaccine Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Split Influenza Vaccine Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Split Influenza Vaccine Sales by Application (2018-2024) & (K Units)
Table 38. Global Split Influenza Vaccine Sales by Application (2024-2029) & (K Units)
Table 39. Global Split Influenza Vaccine Sales Share by Application (2018-2024)
Table 40. Global Split Influenza Vaccine Sales Share by Application (2024-2029)
Table 41. Global Split Influenza Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Split Influenza Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Split Influenza Vaccine Revenue Share by Application (2018-2024)
Table 44. Global Split Influenza Vaccine Revenue Share by Application (2024-2029)
Table 45. Split Influenza Vaccine Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Split Influenza Vaccine Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Split Influenza Vaccine Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Split Influenza Vaccine Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Split Influenza Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Split Influenza Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Split Influenza Vaccine Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Split Influenza Vaccine Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Split Influenza Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Split Influenza Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Split Influenza Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Split Influenza Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Split Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Split Influenza Vaccine Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Split Influenza Vaccine Sales by Country (2024-2029) & (K Units)
Table 60. Europe Split Influenza Vaccine Sales by Type (2018-2024) & (K Units)
Table 61. Europe Split Influenza Vaccine Sales by Type (2024-2029) & (K Units)
Table 62. Europe Split Influenza Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Split Influenza Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Split Influenza Vaccine Sales by Application (2018-2024) & (K Units)
Table 65. Europe Split Influenza Vaccine Sales by Application (2024-2029) & (K Units)
Table 66. Europe Split Influenza Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Split Influenza Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Split Influenza Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Split Influenza Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Split Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Split Influenza Vaccine Sales by Country (2018-2024) & (K Units)
Table 72. Europe Split Influenza Vaccine Sales by Country (2024-2029) & (K Units)
Table 73. China Split Influenza Vaccine Sales by Type (2018-2024) & (K Units)
Table 74. China Split Influenza Vaccine Sales by Type (2024-2029) & (K Units)
Table 75. China Split Influenza Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Split Influenza Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Split Influenza Vaccine Sales by Application (2018-2024) & (K Units)
Table 78. China Split Influenza Vaccine Sales by Application (2024-2029) & (K Units)
Table 79. China Split Influenza Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Split Influenza Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Split Influenza Vaccine Sales by Type (2018-2024) & (K Units)
Table 82. Asia Split Influenza Vaccine Sales by Type (2024-2029) & (K Units)
Table 83. Asia Split Influenza Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Split Influenza Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Split Influenza Vaccine Sales by Application (2018-2024) & (K Units)
Table 86. Asia Split Influenza Vaccine Sales by Application (2024-2029) & (K Units)
Table 87. Asia Split Influenza Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Split Influenza Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Split Influenza Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Split Influenza Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Split Influenza Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Split Influenza Vaccine Sales by Region (2018-2024) & (K Units)
Table 93. Asia Split Influenza Vaccine Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Split Influenza Vaccine Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Split Influenza Vaccine Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Split Influenza Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Split Influenza Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Split Influenza Vaccine Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Split Influenza Vaccine Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Split Influenza Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Split Influenza Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Split Influenza Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Split Influenza Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Split Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Split Influenza Vaccine Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Split Influenza Vaccine Sales by Country (2024-2029) & (K Units)
Table 107. Sanofi Pasteur Company Information
Table 108. Sanofi Pasteur Description and Major Businesses
Table 109. Sanofi Pasteur Split Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Sanofi Pasteur Split Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Sanofi Pasteur Recent Developments
Table 112. CSL Seqirus Company Information
Table 113. CSL Seqirus Description and Major Businesses
Table 114. CSL Seqirus Split Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. CSL Seqirus Split Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. CSL Seqirus Recent Developments
Table 117. GSK Company Information
Table 118. GSK Description and Major Businesses
Table 119. GSK Split Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. GSK Split Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. GSK Recent Developments
Table 122. Seqirus, Inc. Company Information
Table 123. Seqirus, Inc. Description and Major Businesses
Table 124. Seqirus, Inc. Split Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Seqirus, Inc. Split Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Seqirus, Inc. Recent Developments
Table 127. straZeneca Company Information
Table 128. straZeneca Description and Major Businesses
Table 129. straZeneca Split Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. straZeneca Split Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. straZeneca Recent Developments
Table 132. Dalian Yali Peak Company Information
Table 133. Dalian Yali Peak Description and Major Businesses
Table 134. Dalian Yali Peak Split Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Dalian Yali Peak Split Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Dalian Yali Peak Recent Developments
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Split Influenza Vaccine Distributors List
Table 140. Split Influenza Vaccine Customers List
Table 141. Split Influenza Vaccine Market Trends
Table 142. Split Influenza Vaccine Market Drivers
Table 143. Split Influenza Vaccine Market Challenges
Table 144. Split Influenza Vaccine Market Restraints
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Split Influenza Vaccine Product Picture
Figure 2. Global Split Influenza Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Split Influenza Vaccine Market Share by Type in 2022 & 2029
Figure 4. Aldult Product Picture
Figure 5. Child Product Picture
Figure 6. Global Split Influenza Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Split Influenza Vaccine Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Split Influenza Vaccine Report Years Considered
Figure 11. Global Split Influenza Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Split Influenza Vaccine Revenue 2018-2029 (US$ Million)
Figure 13. Global Split Influenza Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Split Influenza Vaccine Revenue Market Share by Region (2018-2029)
Figure 15. Global Split Influenza Vaccine Sales 2018-2029 ((K Units)
Figure 16. Global Split Influenza Vaccine Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Split Influenza Vaccine Sales YoY (2018-2029) & (K Units)
Figure 18. US & Canada Split Influenza Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Split Influenza Vaccine Sales YoY (2018-2029) & (K Units)
Figure 20. Europe Split Influenza Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Split Influenza Vaccine Sales YoY (2018-2029) & (K Units)
Figure 22. China Split Influenza Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Split Influenza Vaccine Sales YoY (2018-2029) & (K Units)
Figure 24. Asia (excluding China) Split Influenza Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Split Influenza Vaccine Sales YoY (2018-2029) & (K Units)
Figure 26. Middle East, Africa and Latin America Split Influenza Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Split Influenza Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Split Influenza Vaccine in the World: Market Share by Split Influenza Vaccine Revenue in 2022
Figure 29. Global Split Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Split Influenza Vaccine Sales Market Share by Type (2018-2029)
Figure 31. Global Split Influenza Vaccine Revenue Market Share by Type (2018-2029)
Figure 32. Global Split Influenza Vaccine Sales Market Share by Application (2018-2029)
Figure 33. Global Split Influenza Vaccine Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Split Influenza Vaccine Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Split Influenza Vaccine Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Split Influenza Vaccine Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Split Influenza Vaccine Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Split Influenza Vaccine Revenue Share by Country (2018-2029)
Figure 39. US & Canada Split Influenza Vaccine Sales Share by Country (2018-2029)
Figure 40. U.S. Split Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Split Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Split Influenza Vaccine Sales Market Share by Type (2018-2029)
Figure 43. Europe Split Influenza Vaccine Revenue Market Share by Type (2018-2029)
Figure 44. Europe Split Influenza Vaccine Sales Market Share by Application (2018-2029)
Figure 45. Europe Split Influenza Vaccine Revenue Market Share by Application (2018-2029)
Figure 46. Europe Split Influenza Vaccine Revenue Share by Country (2018-2029)
Figure 47. Europe Split Influenza Vaccine Sales Share by Country (2018-2029)
Figure 48. Germany Split Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 49. France Split Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 50. U.K. Split Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Split Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Split Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 53. China Split Influenza Vaccine Sales Market Share by Type (2018-2029)
Figure 54. China Split Influenza Vaccine Revenue Market Share by Type (2018-2029)
Figure 55. China Split Influenza Vaccine Sales Market Share by Application (2018-2029)
Figure 56. China Split Influenza Vaccine Revenue Market Share by Application (2018-2029)
Figure 57. Asia Split Influenza Vaccine Sales Market Share by Type (2018-2029)
Figure 58. Asia Split Influenza Vaccine Revenue Market Share by Type (2018-2029)
Figure 59. Asia Split Influenza Vaccine Sales Market Share by Application (2018-2029)
Figure 60. Asia Split Influenza Vaccine Revenue Market Share by Application (2018-2029)
Figure 61. Asia Split Influenza Vaccine Revenue Share by Region (2018-2029)
Figure 62. Asia Split Influenza Vaccine Sales Share by Region (2018-2029)
Figure 63. Japan Split Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Split Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Split Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Split Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 67. India Split Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Split Influenza Vaccine Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Split Influenza Vaccine Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Split Influenza Vaccine Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Split Influenza Vaccine Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Split Influenza Vaccine Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Split Influenza Vaccine Sales Share by Country (2018-2029)
Figure 74. Brazil Split Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Split Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Split Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Split Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Split Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 79. Split Influenza Vaccine Value Chain
Figure 80. Split Influenza Vaccine Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries